2Wang X,Ward PA.Opportunities and challenges of disease biomarkers: a new section in the Journal of Translational Medicine[J]. J Transl Med,2012,10:240.
3Hussain T,Nguyen QT.Molecular imaging for cancer diagnosis and surgery[J].Adv Drug Deliv Rev,2014,66:90-100.
3LEHMANN C U,ALTUWAIJRI M M,LI Y C, et al. Translational research in medical informatics or from theory to practice[J].Methods Inf Med,2008,47(1) :1-3.
4LITTMAN B H,MARIO L D,PLEBANI M,et al. What's next in translational medicine? [J]. Clin Sci (Lond),2007,112(4) :217 227.
5MARINCOLA F M. Translational Medicine:A two-way road [J].Transl Med,2003,1(1) :1-2.
6JEMAL A,SIEGEI. R,WARD E,et al. Cancer statistics,2007 [J]. CA Cancer J Clin,2007,57 (1):43-66.
7KRIS M G. Foreword: challenging the 'one size-fits-all ' approach of chemotherapy and radiotherapy for patients with non-small cell lung cancer [J].Lung Caneer,2008,60(Suppl 2) :S1- 2.
8AMERLING R ,WINCHESTER J F ,RONCO C. Guidelines have done more harm than good [J]. Blood Purif,2008,26(1) :73-76.
9MANDELL B F. Surrogate markers are not 'one size-fits all' [J]. Cleve Clin J Med,2006, 73(5) :416.
10ISSA A M. Personalized medicine and the practice of medicine in the 21st century [J]. Mcgill J Med,2007,10(1):53-57.
